drugset / Trial / NCT06944704

Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice

NCT06944704

Phase 2 Completed 45 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Investigating the efficacy, safety, and molecular mechanism of Pentoxifylline supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice

Timeline

Start
2024-04-03
Primary completion
2025-03-19
Completion
2025-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 400 mg Oral